blockchain and cryptocurrency snippets

France urges Israel to withdraw from the Syrian buffer zone.Since the release of "Keba Article", the refinancing of the first unprofitable enterprise in Shanghai Stock Exchange has been approved, and Dizhe Medicine announced that the company's private placement plan has been approved by Shanghai Stock Exchange. This is the first time that the refinancing of the unprofitable enterprise on the Shanghai Stock Exchange has been approved since the release of "Keba Article". (science and technology innovation board Daily)India's new central bank governor: policy stability is very important and will try to maintain policy continuity.

Huayuan Real Estate: It is planned to transfer the assets and liabilities related to real estate development business to Huayuan Group, the controlling shareholder of the company. Huayuan Real Estate announced the change, and the company is planning major asset sales and related transactions. It is planned to transfer the assets and liabilities related to real estate development business to Huayuan Group, the controlling shareholder of the company, that is, the company plans to transfer 100% equity of Huayuan Real Estate. As of the evaluation benchmark date (April 30, 2024), the company's receivables from Huayuan Real Estate and its subsidiaries are as follows.It is reported that the Bank of Japan thinks that it is no harm to raise interest rates later, but it does not rule out taking action in December. On December 11th, according to informed sources, officials of the Bank of Japan believe that it is not costly to raise interest rates later, and they are still open to taking action next week, depending on data and market trends. The authorities believe that even if the Bank of Japan decides to wait until January or later, it will not pay a huge price, because there are signs that there is little risk that inflation may exceed the target. They also said that if the December meeting proposed to raise interest rates, some officials would not object. According to people familiar with the matter, officials think it is only a matter of time to raise interest rates again, because the economy and inflation are in line with their forecasts. Before announcing the policy decision on December 19, officials will carefully evaluate the data and financial markets before making a final decision.France urges Israel to withdraw from the Syrian buffer zone.

US officials said that the United States is focused on providing Ukraine with the air defense system it needs to defend against Russian missiles and drones.Kremlin: (Asked about Russian Foreign Minister Lavrov's diplomatic means to provide Assad with safe passage) There is nothing to add to this.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)